Sort
15,440 grants matching “organoids”
Alveolar epithelial cell type 2 populations and single cell gene expressions in non-small cell lung cancer progression and drug resistance
$0Jussuf Thomas Kaifi · Harry S. Truman Memorial Va Hospital · I01 · FY2024 · VA
BCCMA: Overcoming chemoresistance in ovarian cancer: Targeting Unique Vulnerabilities in Neuroendocrine-like Ovarian Cancer Cells
$0Sanaz Memarzadeh · Va Greater Los Angeles Healthcare System · I01 · FY2023 · VA
Gut Neuroendocrine Cell Signaling
$0Rodger A. Liddle · Durham Va Medical Center · I01 · FY2019 · VA
Role of environmental toxins in shaping the tumor immune microenvironment
$0Timothy Louis Frankel · Veterans Health Administration · I01 · FY2022 · VA
Surfactant Protein C Mutations and Interstitial Lung Disease
$0Michael Francis Beers · Philadelphia Va Medical Center · I01 · FY2024 · VA
Adipose Tissue Extracellular Vesicles in Colorectal Tumorigenesis
$0Arianne L Theiss · Va Eastern Colorado Health Care System · I01 · FY2022 · VA
Claudin-3, Gut Dysbiosis and Inflammatory Bowel Disease
$0Amar B Singh · Omaha Va Medical Center · I01 · FY2023 · VA
Epigenetic Regulation of Immune Evasion in Bladder Cancer
$0Joshua James Meeks · Jesse Brown Va Medical Center · I01 · FY2022 · VA
Ron Receptor Tyrosine Kinase Signaling in Breast Cancer
$0Susan E Waltz · Cincinnati Va Medical Center Research · I01 · FY2025 · VA
Defining Therapeutic Sensitivity of Patient-Derived Cancer Organoids in Cholangiocarcinoma
$0Jeremy David Kratz · Wm S. Middleton Memorial Veterans Hosp · IK2 · FY2025 · VA
Targeting Sphinogsine-1-phosphate to overcome SNAI1-mediated therapy resistance in rectal cancer
$0Ernest Ramsay Camp · Ralph H Johnson Va Medical Center · I01 · FY2020 · VA
Gut Neuroendocrine Cell Signaling
$0Rodger A. Liddle · Durham Va Medical Center · I01 · FY2022 · VA
The Tumor Immune Microenvironment in Pancreatic Cancer Chemoresistance
$0Eileen S Carpenter · Veterans Health Administration · IK2 · FY2024 · VA
Immune and Genetic Controls of Tissue Regeneration in Mice and Humans
$0Thomas H. Leung · Philadelphia Va Medical Center · I01 · FY2020 · VA
Genome engineering therapeutics for cystinuria and its metabolic consequences.
$0Matthew H Wilson · Veterans Health Administration · I01 · FY2025 · VA
The Role of Dermal Fibroblasts in Skin Cancer
$0Lindsey Nicole Seldin · Veterans Health Administration · IK2 · FY2022 · VA
Cross-comparison of patient-derived xenografts and derivative organoids and cell lines for translational research in hepatocellular carcinoma
$0Terence P Gade · Philadelphia Va Medical Center · I01 · FY2022 · VA
ShEEP Request for ImageXpress Micro Confocal High Content Screening System
$0James Michael Fleckenstein · St. Louis Va Medical Center · IS1 · FY2021 · VA
ShEEP Request for a High-Content Screening (HCS) Platform
$0Dandan Sun · Veterans Health Administration · IS1 · FY2021 · VA
TGFβ and Smad Signaling Components in Esophageal Adenocarcinoma
$0Andrew Edward Blum · Louis Stokes Cleveland Va Medical Center · IK2 · FY2022 · VA
Modulation of Junctional Signaling by BVES in Colorectal Carcinoma
$0Christopher S. Williams · Veterans Health Administration · I01 · FY2022 · VA
The role of eosinophils and oxidative stress in esophageal malignancy
$0Yash Choksi · Veterans Health Administration · IK2 · FY2020 · VA
Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression
$0Keith T Wilson · Veterans Health Administration · I01 · FY2023 · VA
BCCMA: Targeting Gut-Microbiome in Veterans Deployment Related Gastrointestinal and Liver Diseases: Dysbiosis, PTSD, and Epithelial and Immune Biology in Inflammatory Bowel Disease in Veterans
$0Keith T Wilson · Veterans Health Administration · I01 · FY2024 · VA
BLRD Research Career Scientist Award Application
$0Subhra Mohapatra · James A. Haley Va Medical Center · IK6 · FY2021 · VA